{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:03:29Z","timestamp":1789434209842,"version":"build-2803163510"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/aud.0b013e318181ad99","type":"journal-article","created":{"date-parts":[[2008,10,27]],"date-time":"2008-10-27T07:09:34Z","timestamp":1225091374000},"page":"875-893","source":"Crossref","is-referenced-by-count":49,"title":["Factors Affecting Sensitivity of Distortion-Product Otoacoustic Emissions to Ototoxic Hearing Loss"],"prefix":"10.1097","volume":"29","author":[{"given":"Kelly M.","family":"Reavis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Fausti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy J.","family":"Helt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Wilmington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene W.","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Konrad-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210128","first-page":"11","article-title":"Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy.","volume":"36","year":"1994","journal-title":"ASHA"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/archotol.125.2.215","article-title":"High-frequency hearing influences lower-frequency distortion-product otoacoustic emissions.","volume":"125","author":"Arnold","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6123(08)62264-5","article-title":"Exploration of cochlear function by otoacoustic emissions: relationship to pure-tone audiometry.","volume":"97","author":"Avan","year":"1993","journal-title":"Prog Brain Res"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1345\/aph.1A216","article-title":"Ototoxicity induced by gentamicin and furosemide.","volume":"36","author":"Bates","year":"2002","journal-title":"Ann Pharmacother"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3109\/14992020309101328","article-title":"Immediate and short-term reliability of distortion-product otoacoustic emissions.","volume":"42","author":"Beattie","year":"2003","journal-title":"Int J Audiol"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/archotol.1994.01880290051009","article-title":"Risk factors for ototoxicity due to cisplatin.","volume":"120","author":"Blakley","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2165\/00003495-198019060-00002","article-title":"Drug-induced ototoxicity.","volume":"19","author":"Brummett","year":"1980","journal-title":"Drugs"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1128\/AAC.33.6.797","article-title":"Aminoglycoside-induced hearing loss in humans.","volume":"33","author":"Brummett","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0030-6665(20)30774-X","article-title":"Audiologic monitoring for ototoxicity.","volume":"26","author":"Campbell","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1044\/jshd.2404.330","article-title":"Preferred method for clinical determination of pure-tone thresholds.","volume":"24","author":"Carhart","year":"1959","journal-title":"J Speech Hear Disord"},{"key":"R12-6-20210128","first-page":"3797","article-title":"Neuro and ototoxicity of high dose carboplatin treatment in poor prognosis ovarian cancer patients.","volume":"18","author":"Cavaletti","year":"1998","journal-title":"Anticancer Res"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","article-title":"Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 4000 patients.","volume":"88","author":"de Jongh","year":"2003","journal-title":"Br J Cancer"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/010503999424707","article-title":"ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin.","volume":"28","author":"DeLauretis","year":"1999","journal-title":"Scand Audiol"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00003446-200502000-00006","article-title":"Audiometric threshold shift definitions: simulations and suggestions.","volume":"26","author":"Dobie","year":"2005","journal-title":"Ear Hear"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.aud.0000233892.37803.1a","article-title":"Repeatability of high-frequency distortion-product otoacoustic emissions in normal-hearing adults.","volume":"27","author":"Dreisbach","year":"2006","journal-title":"Ear Hear"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/00206098909081626","article-title":"Role of high-frequency audiometry in the early detection of ototoxicity. II. Clinical aspects.","volume":"28","author":"Dreschler","year":"1989","journal-title":"Audiology"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.aud.0000179692.81851.3b","article-title":"Audiometric predictions using stimulus-frequency otoacoustic emissions and middle ear measurements.","volume":"26","author":"Ellison","year":"2005","journal-title":"Ear Hear"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/019459988108900424","article-title":"Cis-diamminedichloroplatinum (II) ototoxicity in the guinea pig.","volume":"89","author":"Estrem","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1121\/1.383643","article-title":"A system for evaluating auditory function from 8000\u201320 000 Hz.","volume":"66","author":"Fausti","year":"1979","journal-title":"J Acoust Soc Am"},{"key":"R21-6-20210128","first-page":"162","article-title":"Reliability and validity of high-frequency (8\u201320 kHz) thresholds obtained on a computer-based audiometer as compared to a documented laboratory system.","volume":"1","author":"Fausti","year":"1990","journal-title":"J Am Acad Audiol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0040-1715935","article-title":"Early detection of ototoxicity using 1\/6th-octave steps.","volume":"14","author":"Fausti","year":"2003","journal-title":"J Am Acad Audiol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003446-199912000-00005","article-title":"An individualized, sensitive frequency range for early detection of ototoxicity.","volume":"20","author":"Fausti","year":"1999","journal-title":"Ear Hear"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archotol.1993.01880180081015","article-title":"High-frequency monitoring for early detection of cisplatin ototoxicity.","volume":"119","author":"Fausti","year":"1993","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/165.6.1026","article-title":"High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.","volume":"165","author":"Fausti","year":"1992","journal-title":"J Infect Dis"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003446-199406000-00004","article-title":"High-frequency audiometric monitoring strategies for early detection of ototoxicity.","volume":"15","author":"Fausti","year":"1994","journal-title":"Ear Hear"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0196-0709(84)80009-5","article-title":"Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies.","volume":"5","author":"Fausti","year":"1984","journal-title":"Am J Otolaryngol"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0196-0709(93)90113-L","article-title":"Mitochondrial ribosomal RNA gene mutation in a patient with sporadic aminoglycoside ototoxicity.","volume":"14","author":"Fischel-Ghodsian","year":"1993","journal-title":"Am J Otolaryngol"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000013861","article-title":"Aminoglycoside antibiotics.","volume":"5","author":"Forge","year":"2000","journal-title":"Audiol Neurootol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00003446-199212000-00008","article-title":"Test\/retest reliability of distortion-product and transiently evoked otoacoustic emissions.","volume":"13","author":"Franklin","year":"1992","journal-title":"Ear Hear"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1121\/1.406691","article-title":"Otoacoustic emissions from normal-hearing and hearing-impaired subjects distortion product responses.","volume":"93","author":"Gorga","year":"1993","journal-title":"J Acoust Soc Am"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003446-199712000-00003","article-title":"From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.","volume":"18","author":"Gorga","year":"1997","journal-title":"Ear Hear"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1121\/1.416208","article-title":"The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements.","volume":"100","author":"Gorga","year":"1996","journal-title":"J Acoust Soc Am"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/00005537-200110000-00025","article-title":"Aminoglycoside ototoxicity: a human temporal bone study.","volume":"111","author":"Hinojosa","year":"2001","journal-title":"Laryngoscope"},{"key":"R35-6-20210128","first-page":"731","article-title":"Temporal bone histopathology of cisplatin ototoxicity.","volume":"16","author":"Hinojosa","year":"1995","journal-title":"Am J Otol"},{"key":"R36-6-20210128","first-page":"269","article-title":"Best practices in oncology management: focus on swallowing and communication disorders","author":"Hodges","year":"1999"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-5955(97)00123-8","article-title":"Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas.","volume":"112","author":"Hofstetter","year":"1997","journal-title":"Hear Res"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0194-5998(98)70276-1","article-title":"Histopathology of human temporal bone after cis-platinum, radiation, or both.","volume":"118","author":"Hoistad","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00003446-199910000-00002","article-title":"Effects of chronic tobramycin treatment on distortion product otoacoustic emissions.","volume":"20","author":"Katbamna","year":"1999","journal-title":"Ear Hear"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02897206","article-title":"Carboplatin is ototoxic.","volume":"26","author":"Kennedy","year":"1990","journal-title":"Cancer Chemother Pharmacol"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-5955(80)90064-7","article-title":"Cochlear mechanics: implications of electrophysiological and acoustical observations.","volume":"2","author":"Kim","year":"1980","journal-title":"Hear Res"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/019459988108900226","article-title":"Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.","volume":"89","author":"Komune","year":"1981","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0196-0709(83)80003-9","article-title":"Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs.","volume":"4","author":"Konishi","year":"1983","journal-title":"Am J Otolaryngol"},{"issue":"(8","key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1288\/00005537-198808000-00014","article-title":"Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing.","volume":"98","author":"Kopelman","year":"1988","journal-title":"Laryngoscope"},{"key":"R45-6-20210128","article-title":"Pharmacotherapy: a pathophysiologic approach (2nd ed., pp. 1349\u20131362).","author":"Lesar","year":"1993"},{"key":"R46-6-20210128","first-page":"257","article-title":"Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study.","volume":"9","author":"Littman","year":"1998","journal-title":"J Am Acad Audiol"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-5955(87)90049-9","article-title":"Acoustic distortion products in rabbits II. Sites of origin revealed by suppression contours and pure-tone exposures.","volume":"28","author":"Martin","year":"1987","journal-title":"Hear Res"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0378-5955(98)00116-6","article-title":"A semiquantitative analysis of the effects of cisplatin on the rat stria vascularis.","volume":"124","author":"Meech","year":"1998","journal-title":"Hear Res"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/149.1.23","article-title":"Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.","volume":"149","author":"Moore","year":"1984","journal-title":"J Infect Dis"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03005364000000004","article-title":"Comparison of distortion product OAE generation between a patient group requiring frequent gentamicin therapy and control subjects.","volume":"31","author":"Mulheran","year":"1997","journal-title":"Br J Audiol"},{"key":"R51-6-20210128","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1121\/1.423876","article-title":"Comparison between intensity and pressure as measures of sound level in the ear canal.","volume":"104","author":"Neeley","year":"1998","journal-title":"J Acoust Soc Am"},{"key":"R52-6-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/00016488209130876","article-title":"Ototoxicity of the anticancer drug cisplatin. An experimental study.","volume":"93","author":"Nakai","year":"1982","journal-title":"Acta Otolaryngol"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000027615","article-title":"The effect of hemodialysis on hearing using pure-tone audiometry and distortion-product otoacoustic emissions.","volume":"60","author":"Ozturan","year":"1996","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R54-6-20210128","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.bmt.1701391","article-title":"Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma.","volume":"22","author":"Parsons","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases.","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R56-6-20210128","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/hn.1999.v121.a101567","article-title":"Effects of cis-platinum chemotherapy on otoacoustic emissions: the development of an objective screening protocol.","volume":"121","author":"Ress","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R57-6-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00206099309072943","article-title":"Repeatability of distortion product otoacoustic emissions in normally hearing humans.","volume":"32","author":"Roede","year":"1993","journal-title":"Audiology"},{"key":"R58-6-20210128","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0.CO;2-F","article-title":"Ototoxicity of low- and moderate-dose cisplatin.","volume":"56","author":"Schaefer","year":"1985","journal-title":"Cancer"},{"issue":"Suppl 59","key":"R59-6-20210128","first-page":"1","article-title":"Cisplatin-induced ototoxicity: effect of pigmentation and inhibitory agents.","volume":"103","author":"Schweitzer","year":"1993","journal-title":"Laryngoscope"},{"key":"R60-6-20210128","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/019459988409200109","article-title":"Ototoxic and nephrotoxic effects of combined treatment with cis-diamminedichloroplatinum and kanamycin in the guinea pig.","volume":"92","author":"Schweitzer","year":"1984","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R61-6-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2165\/00002018-199614030-00006","article-title":"Drug-induced tinnitus and other hearing disorders.","volume":"13","author":"Seligmann","year":"1996","journal-title":"Drug Safety"},{"key":"R62-6-20210128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1121\/1.426948","article-title":"Evoked otoacoustic emissions arise by two fundamentally different mechanisms: a taxonomy for mammalian OAEs.","volume":"105","author":"Shera","year":"1999","journal-title":"J Acoust Soc Am"},{"key":"R63-6-20210128","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1121\/1.409829","article-title":"Ear-canal standing waves and high-frequency sound calibration using otoacoustic emission probes.","volume":"95","author":"Siegel","year":"1994","journal-title":"J Acoust Soc Am"},{"key":"R64-6-20210128","first-page":"416","article-title":"Otoacoustic emissions: clinical applications","author":"Siegel","year":"2002"},{"key":"R65-6-20210128","first-page":"137","article-title":"New perspectives on noise-induced hearing loss","author":"Siegel","year":"1982"},{"key":"R66-6-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5876(01)00455-4","article-title":"Evoked otoacoustic emissions\u2014an approach for monitoring cisplatin induced ototoxicity in children.","volume":"59","author":"Stavroulaki","year":"2001","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"R67-6-20210128","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archotol.128.2.150","article-title":"Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis.","volume":"128","author":"Stavroulaki","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R68-6-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2273.1984.tb01515.x","article-title":"Differences in the cochlear degeneration pattern in the guinea pig as a result of gentamicin and cis-platinum intoxication.","volume":"9","author":"Tange","year":"1984","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"R69-6-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF00464411","article-title":"The importance of high-tone audiometry in monitoring for ototoxicity.","volume":"242","author":"Tange","year":"1985","journal-title":"Arch Otorhinolaryngol"},{"key":"R70-6-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0378-5955(96)00040-8","article-title":"Selective inner hair cell loss does not alter distortion product otoacoustic emissions.","volume":"96","author":"Trautwein","year":"1996","journal-title":"Hear Res"},{"key":"R71-6-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5955(00)00182-9","article-title":"Acute changes in cochlear potentials due to cisplatin.","volume":"149","author":"Tsukasaki","year":"2000","journal-title":"Hear Res"},{"issue":"2","key":"R72-6-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/000348948809700208","article-title":"High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.","volume":"97","author":"van der Hulst","year":"1988","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R73-6-20210128","first-page":"567","article-title":"An efficient test protocol for identification of a limited, sensitive frequency test range for early detection of ototoxicity.","volume":"39","author":"Vaughan","year":"2002","journal-title":"J Rehab Res Develop"},{"key":"R74-6-20210128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00003446-199104000-00003","article-title":"Ototoxicity due to cis-diamminedichloroplatinum in the treatment of ovarian cancer: influence of dosage and schedule of administration.","volume":"12","author":"Waters","year":"1991","journal-title":"Ear Hear"},{"key":"R75-6-20210128","first-page":"199","article-title":"Clinical aspects of hearing","author":"Whitehead","year":"1996"},{"key":"R76-6-20210128","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1121\/1.413810","article-title":"Effects of ear-canal standing waves on measurements of distortion-product otoacoustic emissions.","volume":"98","author":"Whitehead","year":"1995","journal-title":"J Acoust Soc Am"}],"container-title":["Ear &amp; Hearing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AUD.0b013e318181ad99","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T01:09:12Z","timestamp":1709341752000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003446-200812000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":75,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aud.0b013e318181ad99","relation":{},"ISSN":["0196-0202"],"issn-type":[{"value":"0196-0202","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}